• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    10.93 Up 0.64(6.22%) May 22, 3:59PM EDT
    Add to Portfolio
    Prev Close:10.29
    Open:10.04
    Bid:9.27 x 500
    Ask:N/A
    1y Target Est:10.25
    Beta:-0.25
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:10.00 - 10.99
    52wk Range:2.97 - 11.68
    Volume:419,921
    Avg Vol (3m):403,845
    Market Cap:267.29M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):885.96
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.07
    Quarterly EPS Est (Jun-15) :-0.24
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback